Submit Manuscript  

Article Details


The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome

[ Vol. 20 , Issue. 1 ]

Author(s):

Shuqi Pu, Xiaojie Wu, Xiaoying Yang, Yunzhan Zhang, Yunkai Dai, Yueling Zhang, Xiaoting Wu, Yan Liu, Xiaona Cui, Haiyong Jin, Jianhong Cao, Ruliu Li, Jiazhong Cai, Qizhi Cao*, Ling Hu* and Yong Gao*   Pages 15 - 22 ( 8 )

Abstract:


Background: Diabetes, with an increased prevalence and various progressive complications, has become a significant global health challenge. The concrete mechanisms responsible for the development of diabetes still remain incompletely unknown, although substantial researches have been conducted to search for the effective therapeutic targets. This review aims to reveal the novel roles of Xenobiotic Nuclear Receptors (XNRs), including the Peroxisome Proliferator-Activated Receptor (PPAR), the Farnesoid X Receptor (FXR), the Liver X Receptor (LXR), the Pregnane X Receptor (PXR) and the Constitutive Androstane Receptor (CAR), in the development of diabetes and provide potential strategies for research and treatment of metabolic diseases.

Methods: We retrieved a large number of original data about these five XNRs and organized to focus on their recently discovered functions in diabetes and its complications.

Results: Increasing evidences have suggested that PPAR, FXR, LXR ,PXR and CAR are involved in the development of diabetes and its complications through different mechanisms, including the regulation of glucose and lipid metabolism, insulin and inflammation response and related others.

Conclusion: PPAR, FXR, LXR, PXR, and CAR, as the receptors for numerous natural or synthetic compounds, may be the most effective therapeutic targets in the treatment of metabolic diseases.

Keywords:

Xenobiotic Nuclear Receptors (XNRs), Peroxisome Proliferator-Activated Receptor (PPAR), Farnesoid X Receptor (FXR), Liver X Receptor (LXR), Pregnane X Receptor (PXR), Constitutive Androstane Receptor (CAR), diabetes.

Affiliation:

PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, Department of Immunology, Binzhou Medical University, Yantai, Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology and Laboratory of Infection and Immunity, Xuzhou Medical University, Xuzhou, PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, Department of Operating Theatre, Binzhou People’s Hospital, Binzhou, Department of Operating Theatre, Binzhou People’s Hospital, Binzhou, Department of Immunology, Binzhou Medical University, Yantai, Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, Department of Otolaryngology, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, Department of Immunology, Binzhou Medical University, Yantai, PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou

Graphical Abstract:



Read Full-Text article